News
Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...
5h
ScienceAlert on MSNOzempic-Like Drugs Could Treat Chronic Migraines, Trial FindsMedications sold under brand names like Ozempic, Wegovy, and Saxenda have become famous for their weight-loss benefits, but ...
4d
Live Science on MSNDrug slashes migraine days by half in early trial — and it may work with completely 'new mechanism'The obesity drug liraglutide cut migraine days in half in a small trial, though more research is needed to exclude the ...
“Our findings show liraglutide may be effective for treating stubborn, high-frequency migraines in patients with obesity, and ...
A GLP-1 drug led to fewer days with headaches, a small pilot study of migraine sufferers shows. It may work by lowering pressure inside the head.
StockStory.org on MSN12h
Hims & Hers Health’s Q1 Earnings Call: Our Top 5 Analyst QuestionsHims & Hers Health delivered a first quarter that surpassed Wall Street’s expectations, driven by strong adoption of its ...
A common diabetes drug may be the next big thing for migraine relief. In a clinical study, obese patients with chronic ...
Liraglutide, a member of the family of blockbuster weight-loss drugs, reduces headaches by half in a small study.
A recent study suggests that liraglutide, a drug similar to Ozempic, may reduce migraine frequency in obese individuals with ...
Liraglutide, a medication commonly used to treat diabetes, has shown promising results in reducing chronic migraine in ...
GLP-1 drug liraglutide could become a new treatment option for the estimated one in seven people worldwide who live with ...
8d
News-Medical.Net on MSNTirzepatide rewires appetite and slashes calorie intake in new obesity trialA 6-week randomized trial found that tirzepatide significantly reduced energy intake, appetite, and cravings in adults with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results